日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Highly Selective 5-HT(2B) Receptor Antagonist MW073 Mitigates Aggressive Behavior in an Alzheimer's Disease Mouse Model

高选择性5-HT(2B)受体拮抗剂MW073可减轻阿尔茨海默病小鼠模型中的攻击性行为

Acquarone, Erica; Roy, Saktimayee M; Staniszewski, Agnieszka; Watterson, Daniel Martin; Arancio, Ottavio

Optimized 5-HT(2b) inhibitors for neuropsychiatric syndromes with cognitive dysfunction

针对伴有认知功能障碍的神经精神综合征的优化型 5-HT(2b) 抑制剂

Roy, Saktimayee M; Acquarone, Erica; Argyrousi, Elentina K; Zhang, Hong; Staniszewski, Agnieszka; Inoue, Asuka; Ziarek, Joshua J; Arancio, Ottavio; Watterson, D Martin

Discovery of small molecule candidate therapeutics against neuroimmune targets in Alzheimer’s disease

发现针对阿尔茨海默病神经免疫靶点的小分子候选疗法

Islam, Rezwanul; Vrionis, Frank; Hanafy, Khalid A; Eldik, Linda Jo Van; Roy, Saktimayee M; Arancio, Ottavio; Watterson, D Martin

A small molecule p38α MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies

小分子 p38α MAPK 抑制剂 MW150 可减轻混合淀粉样蛋白和血管病变小鼠模型中的行为缺陷和神经元功能障碍

Hilaree N Frazier, David J Braun, Caleb S Bailey, Meggie J Coleman, Verda A Davis, Stephen R Dundon, Christopher J McLouth, Hana C Muzyk, David K Powell, Colin B Rogers, Saktimayee M Roy, Linda J Van Eldik

The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction

阿尔茨海默病中的5HT2b受体:患者脑内水平升高及拮抗剂可减轻淀粉样蛋白和tau蛋白诱导的功能障碍

Acquarone, Erica; Argyrousi, Elentina K; Arancio, Ottavio; Watterson, D Martin; Roy, Saktimayee M

Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology

使用抗炎药物候选物 MW151 进行治疗可部分减轻记忆障碍,并使患有淀粉样蛋白和血管病变的小鼠模型中的海马代谢标志物恢复正常

David J Braun, David K Powell, Christopher J McLouth, Saktimayee M Roy, D Martin Watterson, Linda J Van Eldik

A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction

一种选择性强、可穿透血脑屏障的p38αMAPK抑制剂,有望用于治疗神经系统和神经精神疾病,并能减轻神经炎症和认知功能障碍。

Roy, Saktimayee M; Minasov, George; Arancio, Ottavio; Chico, Laura W; Van Eldik, Linda J; Anderson, Wayne F; Pelletier, Jeffrey C; Watterson, D Martin

111 Changes in proinflammatory cytokines and chemokines in beef steers chronically exposed to endophyte-infected tall fescue seed

111 长期暴露于内生真菌感染的高羊茅种子的肉牛体内促炎细胞因子和趋化因子的变化

Da Silva, Diane M; Woodham, Andrew W; Naylor, Paul H; Egan, James E; Berinstein, Neil L; Kast, W Martin; Eldik, Linda Jo Van; Roy, Saktimayee M; Arancio, Ottavio; Watterson, D Martin; Brown, Alecia R; Poole, Rebecca K; Jackson, McKenzie Lane; Poore, Matthew H; Pickworth, Carrie L; Poole, Daniel H

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

在癌症临床前模型中评估具有 PLK4 交叉潜力的蛋白激酶抑制剂

Amreena Suri, Anders W Bailey, Maurício T Tavares, Hendra Gunosewoyo, Connor P Dyer, Alex T Grupenmacher, David R Piper, Robert A Horton, Tadanori Tomita, Alan P Kozikowski, Saktimayee M Roy, Simone T Sredni

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

通过调节细胞因子产生和认知结果的异构体选择性蛋白激酶抑制剂候选药物保留正常的神经胶质功能

Zhengqiu Zhou, Adam D Bachstetter, Claudia B Späni, Saktimayee M Roy, D Martin Watterson, Linda J Van Eldik